Korean J Pain 20223515965 httpsdoiorg103344kjp202235159 pISSN 20059159 eISSN 20930569 Experimental Research Article Pharmacological interactions intrathecal pregabalin plus tianeptine clopidogrel rat model neuropathic pain Hyung Gon Lee12 Yeo Ok Kim1 Jeong Il Choi12 Xue Hao Han12 Yang Un Shin1 Myung Ha Yoon12 1Department Anesthesiology Pain Medicine Chonnam National University Medical School Gwangju Korea 2BioMedical Sciences Graduate Program BMSGP Chonnam National University Gwangju Korea Received October 15 2021 Revised November 29 2021 Accepted November 29 2021 Handling Editor Jong Yeon Park Correspondence Myung Ha Yoon Department Anesthesiology Pain Medicine Chonnam National University Medical School 42 Jebongro Donggu Gwangju 61469 Korea Tel 82622206895 Fax 82622326294 Email mhyoonjnuackr These authors contributed equally work author Background There unmet need treating neuropathic pain increasing awareness use drug combinations increase effectiveness treatment reduce adverse effects patients neuropathic pain Methods This study performed determine individual combined ef fects pregabalin tianeptine clopidogrel rat model neuropathic pain The model created ligation L5L6 spinal nerve male SpragueDaw ley rats mechanical allodynia confirmed von Frey filaments Drugs administered intrathecal space mechanical allodynia assessed drug interactions estimated isobolographic fixeddose analyses Results Intrathecal pregabalin tianeptine increased mechanical withdraw al threshold dosedependent manner intrathecal clopidogrel little ef fect mechanical withdrawal threshold An additive effect noted pregabalin tianeptine pregabalin clopidogrel Conclusions These findings suggest intrathecal coadministration pregaba lin tianeptine effectively attenuated mechanical allodynia rat model neuropathic pain Thus pregabalin plus tianeptine valid option enhance efficacy neuropathic pain treatment Key Words Chronic Pain Clopidogrel Drug Interactions Hyperalgesia Neuralgia Pregabalin Rats Spinal Nerves Tianeptine INTRODUCTION Neuropathic pain defined International Associa tion Study Pain pain caused lesion dis ease somatosensory nervous 1 It linked poor quality life 78 adults Never theless patients receive proper treatment neuropathic pain 2 diverse mechanisms difficulty diagnosis ineffective treatments ef fects associated treatments 3 Although com bination therapy inconclusive GRADE Grading Recommendations Assessment Development Evaluation classification 3 combined treatment anticonvulsants antidepressant drugs primary drugs neuropathic pain option physi cians expecting synergistic effects approach leads enhanced efficacy reduced effects In addition enable appropriate drug selection based neuropathic pain pathophysiology substantial terest identification novel targets Pregabalin anticonvulsant acts calcium channels results inhibition neurotransmitter This openaccess article distributed terms Creative Commons Attribution NonCommercial License httpcre ativecommonsorglicensesbync40 permits unrestricted noncommercial use distribution reproduction medium provided original work properly cited The Korean Pain Society 2022 Author contributions Hyung Gon Lee Writingmanuscript preparation Yeo Ok Kim Writingmanuscript preparation Jeong Il Choi Data curation Xue Hao Han Investigation Yang Un Shin Investigation Myung Ha Yoon Supervision 59 Korean J Pain 20223515965 wwwepainorg 60 release demonstrated efficacy postherpetic neu ralgia diabetic peripheral neuropathy posttraumatic neuropathic pain 4 Tianeptine antidepressant distinct neurochemical properties selectively enhances serotonin reuptake pub lished studies analgesic effects 5 Recently P2Y12 receptor antagonists garnered attention relationships pathological pain neuropath ic inflammatory pain 67 Clopidogrel P2Y12 recep tor antagonist broadly antiplatelet agent clinical situations This study performed determine individual combined effects pregabalin tianep tine clopidogrel rat model neuropathic pain MATERIALS AND METHODS 1 Animal preparation In experiments Male SpragueDawley rats weigh ing 150180 g rats maintained 12 hr lightdark cycle wellcontrolled temperature 24C Food water provided ad libitum The Institution al Animal Care Use Committee Chonnam National University approved experimental protocol CNU IACUCH201411 2 Neuropathic pain animal model The spinal nerve ligation method induce neu ropathic pain 8 With rats sevoflurane anesthesia left L5 L6 spinal nerves near vertebral column separated tightly ligated 60 silk Rats considered exhibit neuropathy demonstrated mechanical allodynia paw flinching behavior sponse application bending force 4 g If mo tor impairment induced procedure rats euthanized overdose sevoflurane 3 Intrathecal catheterization At 5 days spinal nerve ligation rats sevoflurane anesthesia polyethylene tube PE10 Bec ton Dickinson Co Sparks MD implanted intrathecal space incision atlan tooccipital membrane level lumbar enlarge ment 9 After catheter implantation rats provided recovery period 7 days closely monitored excluded exhibited neurologic deficits 4 Drugs The drugs pregabalin Pfizer Inc New York NY tianeptine JEIL Pharm Co Ltd Seoul Korea clopidogrel hydrogen sulfate Tocris Bioscience Bristol UK drugs dissolved saline Using hand driven gearoperated syringe pump drugs injected solution volume 001 mL intrathecally 001 mL additional normal saline flushed catheter 5 Assessment mechanical allodynia Rats acclimatized 30 minutes separate trans parent container wire mesh floor test conducted calibrated von Frey filaments neath cage hind paw Eight von Frey filaments 04 07 12 20 36 55 85 15 g sequentially applied vertically plantar surface hind paw 5 seconds hair bent After mechanical stimulation von Frey filaments quick paw avoidance considered positive result In accordance method lighter filaments positive reaction heavier filaments negative reaction 10 After positive reaction se ries experiments conducted The lightest filament exhibited withdrawal reaction defined paw withdrawal threshold The absence positive response pressure 15 g von Frey filament regarded cutoff value 6 Experimental paradigm On day experiment 7 days intrathecal nulation rats undergone adaptation time 30 minutes allocated groups experimental control Test drugs randomly delivered In control group intrathecal saline delivered iden tical volume experimental group Rats experiment investigator blinded drug The effects intrathecal tianep tine 30 100 300 μg clopidogrel 100 300 500 μg pregabalin 03 1 3 μg neuropathic pain evalu ated 67 rats group Baseline mechanical withdrawal thresholds checked prior drug injection At 15 30 60 90 120 150 180 minutes intrathecal drug injection paw withdrawal threshold evaluated The maximum drug dose determined based pilot study neurological deficit The antinociceptive effect drugs evaluated percentage maximal possible effect MPE Korean J Pain 20223515965 httpsdoiorg103344kjp202235159 Lee et al MPE post drug threshold post injured baseline threshold cutoff threshold post injured baseline threshold 100 7 Drug interaction Isobolographic fixeddose analyses performed assess drug interactions pregabalin tianepti ne clopidogrel 11 Isobolographic analysis determines equipotent dose drugs From doseresponse curves drugs pregabalin tianeptine 50 ef fective dose ED50 values estimated repre sented result reducing MPE 50 Subsequent ly constant dose ratio based ED50 individual drugs dose response curve combined administra tion drugs obtained Thus tianeptine ED50 pregabalin ED50 tianeptine ED50 pregabalin ED502 tianeptine ED50 pregabalin ED504 tianeptine ED50 pregabalin ED508 injected Thereafter ED50 values mixtures calculated Isobolograms expressed displaying ED50 values drug x y axes respectively line connecting points represents theoretical line additivity Fur thermore magnitude interaction total fraction value Total fraction value ED50 drug 1 combined drug 2 ED50 drug 1 given ED50 drug 2 combined drug 1 ED50 drug 2 given The fractional values indicate portion single ED50 value accounted corresponding ED50 value combination Values near 1 indicate additive interaction values greater 1 imply antagonistic interaction values 1 indicate synergistic interaction Fixeddose analysis examine correlation pregabalin clopidogrel clopidogrel antial lodynic effect A fixed clopidogrel dose 300 μg intra thecally injected pregabalin doses 8 General behavior Additional experiments rats performed evaluate changes behavior highest dose drug pregabalin 3 μg tianeptine 300 μg clopido grel 500 μg Placingstepping righting reflexes assessed motor functions corneal pinna reflexes induced string stimulation cornea ear canal Behavioral changes noted present absent 12 9 Statistical analysis All data expressed mean standard error 61 mean Doseresponse results analyzed oneway analysis variance Bonferroni comparison post hoc analysis The statistical analysis performed ing SPSS 250 software IBM Corp Armonk NY Dose response lines fitted leastsquares linear regres sion ED50 95 confidence intervals calculated accordance method described Tallarida 13 The difference theoretical experimental ED50 values examined ttests P 005 consid ered statistically significant RESULTS Tactile allodynia induced ligation L5 L6 spinal nerves experimental rats paw withdrawal threshold 4 g No behavioral changes observed highest dose drug 3 μg prega balin 300 μg tianeptine 500 μg clopidogrel Fig 1 Pregabalin tianeptine mixture pregaba lin tianeptine injected intrathecally increased mechanical withdrawal threshold dosedependent manner Fig 2 The 11 ratio pregabalin tianeptine showed ad ditive effects isobolographic analysis Fig 3 Although experimental ED50 values lower theoreti cal ED50 values Fig 3 difference significant And total fraction value close 1 indicating additive interaction Table 1 Intrathecal clopidogrel little effect mechani cal withdrawal threshold Fig 2 In addition intrathecal coadministration fixed clopidogrel dose 300 μg pregabalin 03 1 3 μg affect paw withdrawal threshold pregabalin Fig 4 DISCUSSION Traditionally approaches management neuropathic pain comprise conservative pharmacological comple mentary treatments focus symptoms However limited drug effectiveness aging patient population multidrug instructions opioidrelated adverse effects reduce patient compliance 14 Clinical studies far provide sufficient guidance physicians fur ther experimental studies needed overcome problems There increasing awareness use drug combinations reduce adverse effects patients neuropathic pain The combined use drugs pre sumably effective safer monotherapy Syn ergistic effects demonstrated terms actions greater expected individual potencies Korean J Pain 20223515965 Drug interactions neuropathic pain wwwepainorg B l g d o h s e r h t l w r d h t W Tianeptine 16 14 12 10 8 6 4 2 0 Vehicle 30 g cid31 100 cid31 300 cid31 g g 30 60 90 120 150 180 Time min Pregabalin 16 Vehicle 03 g cid31 1 g cid31 3 g cid31 62 A l g d o h s e r h t l w r d h t W C l g d o h s e r h t l w r d h t W 14 12 10 8 6 4 2 0 14 12 10 8 6 4 2 0 30 60 90 120 150 180 Time min Clopidogrel 16 Vehicle 100 g 300 g 500 g cid31 cid31 cid31 30 60 90 120 150 180 Time min Fig 1 Time course curves intrathecal pregabalin A tianeptine B clopidogrel C hind paw withdrawal response spinal nerve ligation Data presented withdrawal threshold g Each line represents means standard error mean 6 rats Pregabalin Tianeptine Clopidogrel Vehicle A 120 100 E P M 80 60 40 20 0 B 120 100 E P M 80 60 40 20 0 Vehicle Pregabalin Tianeptine 1 10 Dose gcid31 100 1000 Vehicle P T8 P T4 P T2 P T Fig 2 Dose response effect intrathecal pregabalin tianeptine clopidogrel A mixture pregabalin tianeptine B hind paw drawal response spinal nerve ligation Data presented percent maximal possible effect MPE Each line represents means standard error mean 6 rats P pregabalin ED50 T tianeptine ED50 ED50 50 effective dose P 005 P 0001 compared vehicle efficacies 15 In present study pregabalin tianeptine relieved tactile allodynia clopidogrel minimal effect allodynia These results indicate pregabalin tianeptine effectively manage spinal nerve ligationinduced neuropathy clopidogrel Pregabalin wellknown anticonvulsant analgesic agent firstline drug neuropathic pain In preclinical clinical settings effectiveness pregabalin established 1617 Various animal Korean J Pain 20223515965 httpsdoiorg103344kjp202235159 Lee et al 63 Pregabalin Pregabalin Clopidogrel 140 120 100 80 60 40 20 g cid31 e n t p e n T T E E P M 125 100 75 50 25 0 0 02 04 06 08 10 Pregabalin gcid31 12 14 16 03 1 Dose gcid31 3 Fig 3 Isobologram interaction intrathecal pregabalin tianeptine The ED50 values agent plotted x axis y axis respectively The experimental ED50 point E significantly different theoretical ED50 point T indicating additive inter action pregabalin tianeptine ED50 50 effective dose Fig 4 A fixed dose analysis interaction intrathecal clopidogrel 300 μg pregabalin Data presented percent maximal possible effect MPE Each line represents means standard error mean 6 rats Table 1 ED50 values μg 95 CI TFV intrathecal drugs Drug ED50 95 CI Pregabalin Tianeptine TianeptineaPregabalin PregabalinaTianeptine 078 056110 10880 874613535 3433 26834392 024 019031 TFV 063 ED50 effective dose producing 50 reduction control response CI confidence intervals TFV total fraction value available aThese values imply ED50 values tianeptine pregabalin mixture tianeptine pregabalin models neuropathic inflammatory pain including spinal nerve ligation revealed effectiveness pregabalin 18 Its effectiveness proven treatment clinical conditions diabetic neuropa thy chemotherapyinduced peripheral neuropathy post herpetic neuralgia fibromyalgia trigeminal neuralgia 18 Similar gabapentin action site pregabalin α2δsubunit voltagegated calcium channels central nervous 19 Blockage site reduce depolarizationinduced calcium influx neu rotransmitter release Reduced levels neurotransmit ters glutamate norepinephrine substance P decrease abnormal neuronal excitability appears promote antinociceptive effects 20 Tianeptine demonstrated antiallodynic effects neuropathic inflammatory pain It superior toler ability compared conventional antidepressant medi cations exhibits fewer effects seda tion cardiovascular changes cognitive changes sexual dysfunction nausea 21 Preclinical studies showed administration tianeptine enhanced extra cellular levels 5HT norepinephrine spinal dorsal horn 22 enhanced 5HT uptake brain reduced stressinduced atrophy neuronal dendrites 23 Therefore serotonergic noradrenergic transmission contribute antinociceptive effect tianeptine Recently opioidrelated mechanism proposed explain antinociceptive effects tianeptine Antago nists opioid receptor types μ δ κ prevented antinociceptive effect tianeptine rats visceral nociception 24 Clopidogrel P2Y12 receptor antagonist broadly antiplatelet agent clinical situations related cardiovascular conditions P2Y12 P2Y metabotropic Gproteincoupled purinergic receptor new target neuropathic pain therapy Previous studies demon strated specific antagonists P2Y12 receptors clopidogrel alleviated tactile allodynia rodent models neuropathic pain 67 However study failed confirm effect P2Y12 receptor antagonist Considering use multidrug treatment clinical practice possibility combination agents im portant issue In present study pregabalin interacted tianeptine additive manner interact clopidogrel These findings suggest mixture pregabalin plus tianeptine provide drug combination benefits mixture clopidogrel plus pregabalin ineffective neuropathic pain man agement Although endpoint pharmacological interactions types agents complicated agents interact altering kinetics tar receptors channels 19 Thus agents different shared mechanisms coadministered synergistic additive interaction expected Previous studies demonstrated synergistic additive interaction Korean J Pain 20223515965 Drug interactions neuropathic pain wwwepainorg 64 drugs 2526 It reported antinoci ceptive effects gabapentin tianeptine reversed opioid receptor antagonist spinal level 2427 On hand serotonergic noradrenergic sys tems involved antinociception tianeptine gabapentin 2427 These findings suggest drugs common pharmacologic site action different mechanisms action In present study experimental ED50 values significantly different theoretical ED50 val ues Furthermore total fraction value close 1 Thus assumed pregabalin interacted tianeptine additively synergistically The absence reinforced interaction prega balin clopidogrel present study ineffectiveness clopidogrel neuropathic pain Notably antiallodynic effect pregabalin observed late stage tianeptine showed anti allodynic effect early stage These phenomena led complementary effects following treatment pregabalin plus tianeptine In conclusion intrathecal injections pregabalin plus tianeptine useful management neuropathic pain The enhanced efficacy combination aid physicians clinical treatment Further investigations needed dose drug clinical setting CONFLICT OF INTEREST No potential conflict relevant article reported FUNDING This study supported grant BCRI180271 Chonnam National University Hospital Biomedical Re search Institute ORCID Hyung Gon Lee httpsorcidorg0000000348984355 Yeo Ok Kim httpsorcidorg0000000217488079 Jeong Il Choi httpsorcidorg0000000235712599 Xue Hao Han httpsorcidorg0000000263696792 Yang Un Shin httpsorcidorg0000000196526637 Myung Ha Yoon httpsorcidorg0000000299620255 REFERENCES 1 IASP Taxonomy neuropathic pain Internet Washington DC IASP 2017 Available httpswwwiasppainorg resourcesterminologyItemNumber1698Neuropathicpa 2 IASP Epidermiolog y neuropat hic pain com mon neuropathic pain impact Inter net Washington DC IASP 2014 Available https wwwiasppainorgadvocacyglobalyearneuropathic painitemNumber3934 3 Finnerup NB Attal N Haroutounian S McNicol E Baron R Dworkin RH et al Pharmacotherapy neuropathic pain adults systematic review metaanalysis Lancet Neu rol 2015 14 16273 4 Derry S Bell RF Straube S Wiffen PJ Aldington D Moore RA Pregabalin neuropathic pain adults Cochrane Da tabase Syst Rev 2019 1 CD007076 5 Heo BH Shin JY Park KS Lee HG Choi JI Yoon MH et al Effects tianeptine development maintenance mechanical allodynia rat model neuropathic pain Neurosci Lett 2016 633 826 6 TozakiSaitoh H Tsuda M Miyata H Ueda K Kohsaka S Inoue K P2Y12 receptors spinal microglia required neuropathic pain peripheral nerve injury J Neurosci 2008 28 494956 7 Yu T Zhang X Shi H Tian J Sun L Hu X et al P2Y12 regu lates microglia activation excitatory synaptic transmis sion spinal lamina II neurons neuropathic pain rodents Cell Death Dis 2019 10 165 8 Kim SH Chung JM An experimental model peripheral neuropathy produced segmental spinal nerve ligation rat Pain 1992 50 35563 9 Yaksh TL Rudy TA Chronic catheterization spinal subarachnoid space Physiol Behav 1976 17 10316 10 Chaplan SR Bach FW Pogrel JW Chung JM Yaksh TL Quantitative assessment tactile allodynia rat paw J Neurosci Methods 1994 53 5563 11 Yoon MH Choi JI Kwak SH Characteristic interactions intrathecal gabapentin clonidine neo stigmine formalin test Anesth Analg 2004 98 13749 12 Yoon MH Choi JI Jeong SW Antinociception intrathecal cholinesterase inhibitors cholinergic receptors rats Acta Anaesthesiol Scand 2003 47 107984 13 Tallarida RJ Drug synergism doseeffect data analysis Boca Raton Chapman HallCRC 2000 14 Colloca L Ludman T Bouhassira D Baron R Dickenson AH Yarnitsky D et al Neuropathic pain Nat Rev Dis Primers 2017 3 17002 15 Tallarida RJ Quantitative methods assessing drug syner gism Genes Cancer 2011 2 10038 16 Sałat K Librowski T Nawiesniak B GluchLutwin M Evalu Korean J Pain 20223515965 httpsdoiorg103344kjp202235159 Lee et al ation analgesic antioxidant cytotoxic metabolic ef fects pregabalin use neuropathic pain Neurol Res 2013 35 94858 17 Zhang SS Wu Z Zhang LC Zhang Z Chen RP Huang YH et al Efficacy safety pregabalin treating painful diabetic peripheral neuropathy metaanalysis Acta An aesthesiol Scand 2015 59 14759 18 Verma V Singh N Singh Jaggi A Pregabalin neuropathic pain evidences possible mechanisms Curr Neurophar macol 2014 12 4456 19 Belliotti TR Capiris T Ekhato IV Kinsora JJ Field MJ Hef fner TG et al Structureactivity relationships pregabalin analogues target alpha2delta protein J Med Chem 2005 48 2294307 20 BenMenachem E Pregabalin pharmacology rel evance clinical practice Epilepsia 2004 45 Suppl 6 138 21 Sindrup SH Otto M Finnerup NB Jensen TS Antidepres sants treatment neuropathic pain Basic Clin Phar macol Toxicol 2005 96 399409 22 Lee HG Choi JI Yoon MH Obata H Saito S Kim WM The antiallodynic effect intrathecal tianeptine exerted increased serotonin norepinephrine spinal dorsal 65 horn Neurosci Lett 2014 583 1037 23 Uzbay TI Tianeptine potential influences neuroplasticity novel pharmacological effects Prog Neuropsychophar macol Biol Psychiatry 2008 32 91524 24 Bilge SS İlkaya F Darakcı Ö Çiftcioğlu E Bozkurt A Opioid receptors contribute antinociceptive effect tianeptine colorectal distensioninduced visceral pain rats Phar macology 2018 101 96103 25 Jung YH Kim YO Han JH Kim YC Yoon MH Isobolographic analysis drug combinations intrathecal BRL52537 κopioid agonist pregabalin calcium channel modula tor AF 353 P2X3 receptor antagonist A804598 P2X7 receptor antagonist neuropathic rats Anesth Analg 2017 125 6707 26 Yoon MH Bae HB Choi JI Jeong SW Chung SS Yoo KY et al Evaluation interaction intrathecal adenosine MK801 NBQX rat formalin pain model Pharmacology 2005 75 15764 27 Yoon MH Choi JI Jeong SW Spinal gabapentin antino ciception mechanisms action J Korean Med Sci 2003 18 25561 Korean J Pain 20223515965 Drug interactions neuropathic pain wwwepainorg